Systemic therapy for elderly patients with non-small cell lung cancer: Where do we stand in 2019?

The 2 articles by Youn et al and Weiss et al in this issue of Cancer confirm that there is no longer room for therapeutic nihilism in the management of older adults with non–small cell lung cancer. Fit elderly patients with preserved Eastern Cooperative Oncology Group performance status should be treated with standard‐of‐care therapies similar to their younger counterparts. [ABSTRACT FROM AUTHOR]